Spencer Pharmaceutical Stock Market Value
| SPPH Stock | USD 0.0001 0.00 0.000003% |
| Symbol | Spencer |
Spencer Pharmaceutical Company Valuation
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spencer Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Spencer Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spencer Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spencer Pharmaceutical.
| 11/29/2025 |
| 12/29/2025 |
If you would invest 0.00 in Spencer Pharmaceutical on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding Spencer Pharmaceutical or generate 0.0% return on investment in Spencer Pharmaceutical over 30 days. Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases More
Spencer Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spencer Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spencer Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
Spencer Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spencer Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spencer Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Spencer Pharmaceutical historical prices to predict the future Spencer Pharmaceutical's volatility.Spencer Pharmaceutical Backtested Returns
We have found four technical indicators for Spencer Pharmaceutical, which you can use to evaluate the volatility of the company. Please validate Spencer Pharmaceutical's Day Median Price of 1.0E-4, daily balance of power of (9,223,372,036,855), and Day Typical Price of 1.0E-4 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Spencer Pharmaceutical are completely uncorrelated. Spencer Pharmaceutical right now has a risk of 0.0%. Please validate Spencer Pharmaceutical day typical price , to decide if Spencer Pharmaceutical will be following its existing price patterns.
Auto-correlation | 0.00 |
No correlation between past and present
Spencer Pharmaceutical has no correlation between past and present. Overlapping area represents the amount of predictability between Spencer Pharmaceutical time series from 29th of November 2025 to 14th of December 2025 and 14th of December 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spencer Pharmaceutical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Spencer Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Spencer Pharmaceutical lagged returns against current returns
Autocorrelation, which is Spencer Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Spencer Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Spencer Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Spencer Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Spencer Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Spencer Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Spencer Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Spencer Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Spencer Pharmaceutical Lagged Returns
When evaluating Spencer Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Spencer Pharmaceutical stock have on its future price. Spencer Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Spencer Pharmaceutical autocorrelation shows the relationship between Spencer Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Spencer Pharmaceutical.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Spencer Pharmaceutical Correlation, Spencer Pharmaceutical Volatility and Spencer Pharmaceutical Alpha and Beta module to complement your research on Spencer Pharmaceutical. For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Spencer Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.